AF
AVNS

Amalgamated Financial’s Avanos Medical AVNS Stock Holding History

Amalgamated Financial’s Portfolio AVNS Stock Details AVNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		$725K Buy
+21,644
New +$697K 0.01% 1342

Other funds holding AVNS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RC
RGM Capital Naples, Florida $2.06B AUM 8.49% 1-Year Est. Return
PIM
Paradice Investment Management Denver, Colorado $532M AUM 29.6% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
WHG
Westwood Holdings Group Dallas, Texas $13.7B AUM 21.48% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Amalgamated Financial's AVNS Position: Q1 2022 in Review

Amalgamated Financial opened a new position in Avanos Medical (AVNS) in Q1 2022: 21,644 shares worth $725K. The stake represents 0.01% of the portfolio and ranks #1342 among its holdings.

299 funds tracked by Wall St. Rank hold AVNS as of Q1 2022.

  • Amalgamated Financial held 21,644 shares of Avanos Medical worth $725K as of Q1 2022.
  • Avanos Medical was a new Amalgamated Financial position in Q1 2022.
  • Avanos Medical made up 0.01% of Amalgamated Financial's portfolio in Q1 2022, its #1342 holding.
  • 299 funds tracked by Wall St. Rank held Avanos Medical as of Q1 2022.

Based on Amalgamated Financial's 13F filing for Q1 2022, filed 16 May 2022.